NSN Co. Ltd (031860) - Total Assets
Based on the latest financial reports, NSN Co. Ltd (031860) holds total assets worth ₩60.96 Billion KRW (≈ $41.31 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See net assets of NSN Co. Ltd for net asset value and shareholders' equity analysis.
NSN Co. Ltd - Total Assets Trend (2006–2024)
This chart illustrates how NSN Co. Ltd's total assets have evolved over time, based on quarterly financial data.
NSN Co. Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
NSN Co. Ltd's total assets of ₩60.96 Billion consist of 35.8% current assets and 64.2% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩8.44 Billion | 0.0% |
| Accounts Receivable | ₩4.45 Billion | 7.9% |
| Inventory | ₩1.47 Billion | 2.6% |
| Property, Plant & Equipment | ₩5.24 Billion | 9.3% |
| Intangible Assets | ₩100.68 Million | 0.2% |
| Goodwill | ₩450.21 Million | 0.8% |
Asset Composition Trend (2006–2024)
This chart illustrates how NSN Co. Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see NSN Co. Ltd stock valuation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: NSN Co. Ltd's current assets represent 35.8% of total assets in 2024, an increase from 0.0% in 2006.
- Cash Position: Cash and equivalents constituted 0.0% of total assets in 2024, down from 4.2% in 2006.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2006.
- Asset Diversification: The largest asset category is cash and equivalents at 0.0% of total assets.
NSN Co. Ltd Competitors by Total Assets
Key competitors of NSN Co. Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Revvity Inc.
NYSE:RVTY
|
USA | $12.17 Billion |
|
Sonic Healthcare Ltd
AU:SHL
|
Australia | AU$17.03 Billion |
|
Fleury S.A.
SA:FLRY3
|
Brazil | R$13.22 Billion |
|
Shanghai Labway Clinical Laboratory Co Ltd
SHE:301060
|
China | CN¥2.43 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Bcal Diagnostics Ltd
AU:BDX
|
Australia | AU$7.17 Million |
|
Avricore Health Inc
V:AVCR
|
Canada | CA$1.33 Million |
|
Integral Diagnostics Ltd
AU:IDX
|
Australia | AU$1.43 Billion |
NSN Co. Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.95 | 3.96 | 2.16 |
| Quick Ratio | 0.82 | 3.38 | 2.06 |
| Cash Ratio | 0.00 | 0.49 | 0.00 |
| Working Capital | ₩-881.59 Million | ₩7.58 Billion | ₩12.27 Billion |
NSN Co. Ltd - Advanced Valuation Insights
This section examines the relationship between NSN Co. Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.23 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -15.0% |
| Total Assets | ₩56.16 Billion |
| Market Capitalization | $8.50 Million USD |
Valuation Analysis
Below Book Valuation: The market values NSN Co. Ltd's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: NSN Co. Ltd's assets decreased by 15.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for NSN Co. Ltd (2006–2024)
The table below shows the annual total assets of NSN Co. Ltd from 2006 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩56.16 Billion ≈ $38.06 Million |
-15.02% |
| 2023-12-31 | ₩66.08 Billion ≈ $44.78 Million |
-20.31% |
| 2022-12-31 | ₩82.93 Billion ≈ $56.20 Million |
+27.76% |
| 2021-12-31 | ₩64.91 Billion ≈ $43.99 Million |
+6.02% |
| 2020-12-31 | ₩61.22 Billion ≈ $41.49 Million |
-10.40% |
| 2019-12-31 | ₩68.33 Billion ≈ $46.31 Million |
+122.77% |
| 2018-12-31 | ₩30.67 Billion ≈ $20.79 Million |
-5.80% |
| 2017-12-31 | ₩32.56 Billion ≈ $22.07 Million |
-28.39% |
| 2016-12-31 | ₩45.47 Billion ≈ $30.82 Million |
+15.99% |
| 2015-12-31 | ₩39.20 Billion ≈ $26.57 Million |
+2.93% |
| 2014-12-31 | ₩38.09 Billion ≈ $25.81 Million |
+7.29% |
| 2013-12-31 | ₩35.50 Billion ≈ $24.06 Million |
-81.91% |
| 2012-12-31 | ₩196.25 Billion ≈ $132.99 Million |
+14.69% |
| 2011-12-31 | ₩171.11 Billion ≈ $115.96 Million |
+14.07% |
| 2010-12-31 | ₩150.00 Billion ≈ $101.66 Million |
+526.43% |
| 2007-12-31 | ₩23.95 Billion ≈ $16.23 Million |
+3.19% |
| 2006-12-31 | ₩23.21 Billion ≈ $15.73 Million |
-- |
About NSN Co. Ltd
DHX Company Co., Ltd. engages in biomedical and distribution businesses in South Korea. The company offers Microbiome to treat intractable skin diseases; REJURUB; and AI digital brain diagnostic device. It also purchases and distributes IT components, including graphics cards, DRAM, CPUs, high-capacity storage, and multi-purpose displays; import and distribution of cosmetics; f and b distribution… Read more